HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Stephen Poor Selected Research
Stephen Poor Research Topics
Disease
7
Macular Degeneration (Age-Related Maculopathy)
01/2023 - 01/2014
3
Choroidal Neovascularization
01/2018 - 01/2014
1
Doyne honeycomb retinal dystrophy
01/2023
1
Vision Disorders (Hemeralopia)
01/2022
1
Geographic Atrophy
01/2021
1
Atrophy
01/2021
1
Vascular Diseases (Vascular Disease)
01/2017
1
Retinal Diseases
01/2017
1
Corneal Neovascularization
01/2014
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2014
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2017 - 12/2015
2
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
01/2018 - 12/2015
1
Complement Factor B (Factor B)
IBA
01/2023
1
Therapeutic Uses
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
01/2021
1
chemotactic factor inactivator
IBA
01/2021
1
Messenger RNA (mRNA)
IBA
01/2021
1
acrizanib
IBA
01/2018
1
Peptides (Polypeptides)
IBA
01/2017
1
Ranibizumab (Lucentis)
FDA Link
01/2017
1
aflibercept
IBA
01/2017
1
Retinaldehyde (Retinal)
IBA
01/2017
1
Myeloid Differentiation Factor 88
IBA
01/2014
1
Toll-Like Receptor 2
IBA
01/2014
Therapy/Procedure
3
Therapeutics
01/2018 - 12/2015
1
Topical Administration
01/2018
1
Intravitreal Injections
01/2018
1
Lasers (Laser)
01/2014